Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
160 participants
INTERVENTIONAL
2013-07-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Running related injuries can cause a long rehabilitation and may even force the runner to quit running permanently. To ensure that running can be practiced as a safe exercise activity prevention must be considered.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Focus of a Running Schedule and Risk of Running Injuries
NCT02349373
Serial Movement Assessment in Collegiate Athletes Who Perform Injury Prevention Training
NCT04748718
Skeletal Muscle Strain Injuries and the Connective Tissue: Characterization, Recovery and Optimal Treatment
NCT02152098
The Importance of Exercise to Prevent Injuries in Athletes
NCT04078256
The Effectiveness of a Running-related Injury Prevention Program in Runners
NCT03892239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to avoiding training errors, especially excessive volume many novice runners follow 0-5 kilometres type training programmes. However, limited research has been conducted on the training volume of beginner programs and the risk of running related injuries.
The purpose of this study is to investigate the relationship between the running volume the first 4 weeks of a running regime and the risk of running related injuries among novice runners. The relationship between running volume and running related injuries will be investigated in proportion to their body mass index (BMI).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Running training programmes
Runners with a high body mass index are going to follow a training programme of 3 kilometres per week compared to a training programme of 6 kilometres per week.
The amount of running will be increased with 10 % per week.
Training programmes
Runners with a high body mass index follow two types of training programmes:
1. a running programme of 3 kilometres per week
2. a running programme 6 kilometres per week
The amount of running will be increased with 10 % per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training programmes
Runners with a high body mass index follow two types of training programmes:
1. a running programme of 3 kilometres per week
2. a running programme 6 kilometres per week
The amount of running will be increased with 10 % per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no running-training within the last year
* less than 20 hours of sports activity within the last year (in total)
* internet access and mail address
* body mass index between 18.5 - 25 or 30-35
* owns a pair of running shoes
Exclusion Criteria
* unable or unwilling to follow the running regime in 4 consecutive weeks
* previous injury in lower extremity within the last 2 years
* unable to read or understand Danish
* former heart surgery
* known heart surgery
* known lung disease
* diabetes
* current pregnancy
* known tendency to shortness of breath or chest pain with activity
* known tendency to leg pain when walking long distances
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Northern Orthopaedic Division, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael L. Bertelsen, PT
Role: STUDY_CHAIR
Department of Publich Health, Aarhus University
Sten Rasmussen, MD
Role: PRINCIPAL_INVESTIGATOR
Northern Orthopaedic Division, Aalborg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sten Rasmussen
Aalborg, Northern Jutland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Michael L. Bertelsen, PT
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20130035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.